Enfuvirtid je 36 aminokiselina dug sintetički peptid koji inhibira HIV-1 fuziju sa CD4 ćelijama. On je acetilisan na N-kraju.[6][7][8]

Enfuvirtid
Klinički podaci
Robne marke Fuzeon
AHFS/Drugs.com Monografija
Identifikatori
CAS broj 159519-65-0
ATC kod J05AX07
PubChem[1][2] 16130199
DrugBank DB00109
ChemSpider[3] 16743716
UNII 19OWO1T3ZE YesY
KEGG[4] D02499 YesY
ChEBI CHEBI:608828 YesY
ChEMBL[5] CHEMBL525076 YesY
Hemijski podaci
Formula C202H298N50O64 
Mol. masa 4492,1 g/mol
SMILES eMolekuli & PubHem
Farmakokinetički podaci
Bioraspoloživost 84,3% (SC)
Vezivanje za proteine plazme 92%
Metabolizam Hepatički
Poluvreme eliminacije 3.8 sata
Izlučivanje nepoznato
Farmakoinformacioni podaci
Trudnoća ?
Pravni status S4 (Au), POM (UK), ℞-only (SAD)
Način primene Subkutano (SC)

Strukturna formulaUredi

 

Ac-Tyr-Thr-Ser-Leu-Ile-His-Ser-Leu-Ile-Glu-Glu-Ser-Gln-Asn-Gln-Gln-Glu-Lys-Asn-Glu-Gln-Glu-Leu-Leu-Glu-Leu-Asp-Lys-Trp-Ala-Ser-Leu-Trp-Asn-Trp-Phe-NH2

ReferenceUredi

  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. http://www.sciencedirect.com/science/article/pii/S1359644610007737.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. http://www.jcheminf.com/content/2/1/3.  edit
  4. Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H. http://onlinelibrary.wiley.com/doi/10.1002/%28SICI%291097-0061%28200004%2917:1%3C48::AID-YEA2%3E3.0.CO;2-H/full. 
  5. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.  edit
  6. Greenberg ML, Cammack N: Resistance to enfuvirtide, the first HIV fusion inhibitor. J Antimicrob Chemother. 2004 Aug;54(2):333-40. Epub 2004 Jul 1. PMID 15231762
  7. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035-41. PMID 21059682. 
  8. Nucleic Acids Res (2008). DrugBank: a knowledgebase for drugs, drug actions and drug targets. 36. pp. D901-6. PMID 18048412. 

Spoljašnje vezeUredi

  Molimo Vas, obratite pažnju na važno upozorenje u vezi tema o zdravlju (medicini).